Inosine and interferon β 1a:: preliminary results of a clinical trial in multiple sclerosis

被引：0
|
作者：
García, DM
Marín, M
López, J
Arias, M
Dapena, D
Alonso-Alonso, M
Martínez, J
Vázquez, F
机构：
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S272 / S272
页数：1
相关论文
共 50 条
  • [1] Associated Inosine to interferon: results of a clinical trial in multiple sclerosis
    Munoz Garcia, D.
    Midaglia, L.
    Martinez Vilela, J.
    Marin Sanchez, M.
    Lopez Gonzalez, F. J.
    Arias Gomez, M.
    Dapena Bolano, D.
    Iglesias Castanon, A.
    Alonso Alonso, M.
    Romero Lopez, J.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (06): : 405 - 410
  • [2] A preliminary metabolomic study of patients with multiple sclerosis treated with interferon β 1a
    Cocco, E.
    Lorefice, L.
    Murgia, F.
    Barberini, L.
    Frau, J.
    Fenu, G.
    Coghe, G.
    Melis, M.
    Murru, M. R.
    Murru, R.
    Poddighe, S.
    Atzori, L.
    Marrosu, M. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 264 - 264
  • [3] 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a:: results of a preliminary study
    Sarchielli, P
    Presciutti, O
    Tarducci, R
    Gobbi, G
    Alberti, A
    Pelliccioli, GP
    Orlacchio, A
    Gallai, V
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (02): : 204 - 212
  • [4] Interferon β-1a for early multiple sclerosis:: CHAMPS trial subgroup analyses
    Beck, RW
    Chandler, DL
    Cole, SR
    Simon, JH
    Jacobs, LD
    Kinkel, RP
    Selhorst, JB
    Rose, JW
    Cooper, JA
    Rice, G
    Murray, TJ
    Sandrock, AW
    [J]. ANNALS OF NEUROLOGY, 2002, 51 (04) : 481 - 490
  • [5] Safety and tolerability of Inosine plus subcutaneous interferon β1a (IFNβ1a) in Multiple Sclerosis:: Could Inosine protect from IFNβ1a-related adverse effects?
    Garcia, DM
    Marin, M
    Lopez, J
    Arias, M
    Dapena, D
    Martinez, J
    Alonso-Alonso, M
    Vazquez, F
    [J]. NEUROLOGY, 2005, 64 (06) : A385 - A385
  • [6] Interferon-β1a for the treatment of multiple sclerosis
    Clerico, Marinella
    Contessa, Giulia
    Durelli, Luca
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (04) : 535 - 542
  • [7] Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis
    Ghasami, Keyvan
    Faraji, Fardin
    Fazeli, Masoud
    Ghazavi, Ali
    Mosayebi, Ghasem
    [J]. IRANIAN JOURNAL OF IMMUNOLOGY, 2016, 13 (01) : 16 - 26
  • [8] An open-label randomised clinical trial of atorvastatin in combination with IFN Beta 1a in active multiple sclerosis patients: preliminary results
    Orefice, G.
    Quarantelli, M.
    Lanzillo, R.
    Brunetti, A.
    Salvatore, P.
    Prinster, A.
    Vacca, G.
    Mollica, C.
    Bonavita, V.
    Morra, V. Brescia
    Prinster, A.
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 : 179 - 179
  • [9] MULTIPLE SCLEROSIS, PSYCHOSIS AND THE USE OF INTERFERON BETA 1A: A RARE CLINICAL CASE
    Ramos, J. A.
    Costa, A. M.
    [J]. EUROPEAN PSYCHIATRY, 2013, 28
  • [10] A TRIAL OF GAMMA-INTERFERON IN MULTIPLE-SCLEROSIS - CLINICAL-RESULTS
    PANITCH, HS
    HALEY, AS
    HIRSCH, RL
    JOHNSON, KP
    [J]. NEUROLOGY, 1986, 36 (04) : 285 - 285
12345